Growth hormone deficiency and combined pituitary hormone deficiency: Does the genotype matter?

Clinical Endocrinology

Volumn 63, Issue 2, 2005, Pages 121-130

  Dattani, Mehul T ^a  

^a Biochemistry   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HOMEODOMAIN PROTEIN; HYPOPHYSIS HORMONE; LIM PROTEIN; SONIC HEDGEHOG PROTEIN; TRANCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR LHX3; TRANSCRIPTION FACTOR LHX4; TRANSCRIPTION FACTOR PIT 1; TRANSCRIPTION FACTOR PITX2; TRANSCRIPTION FACTOR PROP1; TRANSCRIPTION FACTOR SOX3; TRASCRIPTION FACTOR HESX1; UNCLASSIFIED DRUG;

GENE MUTATION; GENOTYPE; GROWTH HORMONE DEFICIENCY; HOLOPROSENCEPHALY; HUMAN; HYPOPHYSIS DISEASE; HYPOPITUITARISM; INFUNDIBULUM; INHERITANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SEPTOOPTIC DYSPLASIA; X CHROMOSOME LINKED DISORDER;

DNA-BINDING PROTEINS; GENES; GENOTYPE; HOMEODOMAIN PROTEINS; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; LINKAGE (GENETICS); MUTATION; PITUITARY GLAND; PITUITARY HORMONES; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTION FACTORS;

EID: 23244433749     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02289.x     Document Type: Review

References (73)

1. Lacey, K.A. & Parkin, J.M. (1974) Causes of short stature. A community study of children in Newcastle upon Tyne. Lancet, 1, 42-45.
2. Rona, R.J. & Tanner, J.M. (1977) Aetiology of idiopathic growth hormone deficiency in England and Wales. Archives of Disease in Childhood, 52, 197-208.
3. Vimpani, G.V., Vimpani, A.F., Lidgard, G.P., Cameron, E.H. & Farquhar, J.W. (1977) Prevalence of severe growth hormone deficiency. British Medical Journal, 2, 427-430.
4. Phillips, J.A. III & Cogan, J.D. (1994) Genetic basis of endocrine disease. 6. Molecular basis of familial human growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 78, 11-16.
5. Dattani, M.T. & Robinson, I.C. (2000) The molecular basis for developmental disorders of the pituitary gland in man. Clinical Genetics, 57, 337-346.
6. Takuma, N., Sheng, H.Z., Furuta, Y., Ward, J.M., Sharma, K., Hogan, L.M., Pfaff, S.L., Westphal, H., Kimura, S. & Anderson, K.A. (1998) Formation of Rathke's pouch requires dual induction from the diencephalon. Development, 125, 4835-4840.
7. Cohen, L.E. & Radovick, S. (2002) Molecular basis of combined pituitary hormone deficiencies. Endocrine Reviews, 23, 431-442.
8. Dasen, J.S., Barbera, J.P., Herman, T.S., Connell, S.O., Olson, L., Ju, B., Tollkuhn, J., Baek, S.H., Rose, D.W. & Rosenfeld, M.G. (2001) Temporal regulation of a paired-like homeodomain repressor/TLE corepressor complex and a related activator is required for pituitary organogenesis. Genes and Development, 15, 3193-3207.
9. Thomas, P.Q., Johnson, B.V., Rathjen, J. & Rathjen, P.D. (1995) Sequence, genomic organization, and expression of the novel homeobox gene Hesx1. Journal of Biological Chemistry, 270, 3869-3875.
10. Hermesz, E., Mackem, S. & Mahon, K.A. (1996) Rpx: a novel anterior-restricted homeobox gene progressively activated in the prechordal plate, anterior neural plate and Rathke's pouch of the mouse embryo. Development, 122, 41-52.
11. Thomas, P. & Beddington, R. (1996) Anterior primitive endoderm may be responsible for patterning the anterior neural plate in the mouse embryo. Current Biology, 6, 1487-1496.
12. Brickman, J.M., Clements, M., Tyrell, R., McNay, D., Woods, K., Warner, J., Stewart, A., Beddington, R.S. & Dattani, M. (2001) Molecular effects of novel mutations in Hesx1/HESX1 associated with human pituitary disorders. Development, 128, 5189-5199.
13. Dattani, M.T., Martinez Barbera, J.P., Thomas, P.Q., Brickman, J.M., Gupta, R., Martensson, I.L., Toresson, H., Fox, M., Wales, J.K., Hindmarsh, P.C., Krauss, S., Beddington, R.S. & Robinson, I.C. (1998) Mutations in the homeobox gene HESX1/Hesx1 associated with septo-optic dysplasia in human and mouse. Nature Genetics, 19, 125-133.
14. Morishima, A. & Aranoff, G.S. (1986) Syndrome of septo-optic- pituitary dysplasia: the clinical spectrum. Brain Development, 8, 233-239.
15. Brodsky, M.C. & Glasier, C.M. (1993) Optic nerve hypoplasia. Clinical significance of associated central nervous system abnormalities on magnetic resonance imaging. Archives of Ophthalmology, 111, 66-74.
16. Zeki, S.M., Hollman, A.S. & Dutton, G.N. (1992) Neuroradiological features of patients with optic nerve hypoplasia. Journal of Pediatric Ophthalmology and Strabismus, 29, 107-112.
17. Birkebaek, N.H., Patel, L., Wright, N.B., Grigg, J.R., Sinha, S., Hall, C.M., Price, D.A., Lloyd, I.C. & Clayton, P.E. (2003) Endocrine status in patients with optic nerve hypoplasia: relationship to midline central nervous system abnormalities and appearance of the hypothalamic-pituitary axis on magnetic resonance imaging. Journal of Clinical Endocrinology and Metabolism, 88, 5281-5286.
18. Nanduri, V.R. & Stanhope, R. (1999) Why is the retention of gonadotrophin secretion common in children with panhypopituitarism due to septo-optic dysplasia? European Journal of Endocrinology, 140, 48-50.
19. Roberts-Harry, J., Green, S.H. & Willshaw, H.E. (1990) Optic nerve hypoplasia: associations and management. Archives of Diseases of Childhood, 65, 103-106.
20. Carvalho, L.R., Woods, K.S., Mendonca, B.B., Marcal, N., Zamparini, A.L., Stifani, S., Brickman, J.M., Arnhold, I.J. & Dattani, M.T. (2003) A homozygous mutation in HESX1 is associated with evolving hypopituitarism due to impaired repressor-corepressor interaction. Journal of Clinical Investigation, 112, 1192-1201.
21. Thomas, P.Q., Dattani, M.T., Brickman, J.M., McNay, D., Warne, G., Zacharin, M., Cameron, F., Hurst, J., Woods, K., Dunger, D., Stanhope, R., Forrest, S., Robinson, I.C. & Beddington, R.S. (2001) Heterozygous HESX1 mutations associated with isolated congenital pituitary hypoplasia and septo-optic dysplasia. Human Molecular Genetics, 10, 39-45.
22. Tajima, T., Hattorri, T., Nakajima, T., Okuhara, K., Sato, K., Abe, S., Nakae, J. & Fujieda, K. (2003) Sporadic heterozygous frameshift mutation of HESX1 causing pituitary and optic nerve hypoplasia and combined pituitary hormone deficiency in a Japanese patient. Journal of Clinical Endocrinology and Metabolism, 88, 45-50.
23. Cohen, R.N., Cohen, L.E., Botero, D., Yu, C., Sagar, A., Jurkiewicz, M. & Radovick, S. (2003) Enhanced repression by HESX1 as a cause of hypopituitarism and septooptic dysplasia. Journal of Clinical Endocrinology and Metabolism, 88, 4832-4839.
24. Suh, H., Gage, P.J., Drouin, J. & Camper, S.A. (2002) Pitx2 is required at multiple stages of pituitary organogenesis: pituitary primordium formation and cell specification. Development, 129, 329-337.
25. Semina, E.V., Reiter, R., Leysens, N.J., Alward, W.L., Small, K.W., Datson, N.A., Siegel-Bartelt, J., Bierke-Nelson, D., Bitoun, P., Zabel, B.U., Carey, J.C. & Murray, J.C. (1996) Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nature Genetics, 14, 392-399.
26. Lin, C.R., Kioussi, C., O'Connell, S., Briata, P., Szeto, D., Liu, F., Izpisua-Belmonte, J.C. & Rosenfeld, M.G. (1999) Pitx2 regulates lung asymmetry, cardiac positioning and pituitary and tooth morphogenesis. Nature, 401, 279-282.
27. Tremblay, J.J., Lanctot, C. & Drouin, J. (1998) The pan-pituitary activator of transcription, Ptx1 (pituitary homeobox 1), acts in synergy with SF-1 and Pit1 and is an upstream regulator of the Lim-homeodomain gene Lim3/Lhx3. Molecular Endocrinology, 12, 428-441.
28. Sheng, H.Z., Zhadanov, A.B., Mosinger, B., Fujii, T., Bertuzzi, S., Grinberg, A., Lee, E.J., Huang, S.P., Manon, K.A. & Westphal, H. (1996) Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science, 272, 1004-1007.
29. Sheng, H.Z., Moriyama, K., Yamashita, T., Li, H., Potter, S.S., Mahon, K.A. & Westphal, H. (1997) Multistep control of pituitary organogenesis. Science, 278, 1809-1812.
30. Netchine, I., Sobrier, M.L., Krude, H., Schnabel, D., Maghnie, M., Marcos, E., Duriez, B., Cacheux, V., Moers, Av., Goossens, M., Gruters, A. & Amselem, S. (2000) Mutations in LHX3 result in a new syndrome revealed by combined pituitary hormone deficiency. Nature Genetics, 25, 182-186.
31. Machinis, K., Pantel, J., Netchine, I., Leger, J., Camand, O.J., Sobrier, M.L., Dastot-Le Moal, F., Duquesnoy, P., Abitbol, M., Czernichow, P. & Amselem, S. (2001) Syndromic short stature in patients with a germline mutation in the LIM homeobox LHX4. American Journal of Human Genetics, 69, 961-968.
32. Roessler, E., Belloni, E., Gaudenz, K., Vargas, F., Scherer, S.W., Tsui, L.C. & Muenke, M. (1997) Mutations in the C-terminal domain of Sonic Hedgehog cause holoprosencephaly. Human Molecular Genetics, 6, 1847-1853.
33. Roessler, E.Y.Z., Mullor, J.L., Casas, E., Allen, W.P., Gillessen-Kaesbach, G., Roeder, E.R., Ming, J.E., Altaba, A. & Muenke, M. (2003) Loss-of-function mutations in the human GLI2 gene are associated with pituitary anomalies and holoprosencephaly-like features. Proceedings of the National Academy of Sciences of the United States of America, 100, 13424-13429.
34. Solomon, N.M., Nouri, S., Warne, G.L., Lagerstrom-Fermer, M., Forrest, S.M. & Thomas, P.Q. (2002) Increased gene dosage at Xq26-q27 is associated with X-linked hypopituitarism. Genomics, 79, 553-559.
35. Solomon, N.M., Ross, S.A., Morgan, T., Belsky, J.L., Hol, F.A., Karnes, P.S., Hopwood, N.J., Myers, S.E., Tan, A.S., Warne, G.L., Forrest, S.M. & Thomas, P.Q. (2004) Array comparative genomic hybridisation analysis of boys with X linked hypopituitarism identifies a 3.9 Mb duplicated critical region at Xq27 containing SOX3. Journal of Medical Genetics, 41, 669-678.
36. Laumonnier, F., Ronce, N., Hamel, B.C., Thomas, P., Lespinasse, J., Raynaud, M., Paringaux, C., Van Bokhoven, H., Kalscheuer, V., Fryns, J.P., Chelly, J., Moraine, C. & Briault, S. (2002) Transcription factor SOX3 is involved in X-linked mental retardation with growth hormone deficiency. American Journal of Human Genetics, 71, 1450-1455.
37. Woods, K.S., Cundall, M., Turton, J., Rizotti, K., Mehta, A., Palmer, R., Wong, J., Chong, W.K., Al-Zyoud, M., El-Ali, M., Otonkoski, T., Martinez-Barbera, J.P., Thomas, P.Q., Robinson, I.C., Lovell-Badge, R., Woodward, K.J. & Dattani, M.T. (2005) Over- and underdosage of SOX3 Is associated with infundibular hypoplasia and hypopituitarism. American Journal of Human Genetics, 76, 833-849.
38. Scully, K.M. & Rosenfeld, M.G. (2002) Pituitary development: regulatory codes in mammalian organogenesis. Science, 295, 2231-2235.
39. Sornson, M.W., Wu, W., Dasen, J.S., Flynn, S.E., Norman, D.J., O'Connell, S.M., Gukovsky, I., Carriere, C., Ryan, A.K., Miller, A.P., Zuo, L., Gleiberman, A.S., Andersen, B., Beamer, WG. & Rosenfeld, M.G. (1996) Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature, 384, 327-333.
40. Wu, W., Cogan, J.D., Pfaffle, R.W., Dasen, J.S., Frisch, H., O'Connell, S.M., Flynn, S.E., Brown, M.R., Mullis, P.E., Parks, J.S., Phillips, J.A. & Rosenfeld, M.G. (1998) Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nature Genetics, 18, 147-149.
41. Cohen, L.E., Wondisford, F.E., Salvatoni, A., Maghnie, M., Brucker-Davis, F., Weintraub, B.D. & Radovick, S. (1995) A 'hot spot' in the Pit-1 gene responsible for combined pituitary hormone deficiency: clinical and molecular correlates. Journal of Clinical Endocrinology and Metabolism, 80, 679-684.
42. Cogan, J.D., Wu, W., Phillips, J.A. III, Arnhold, I.J., Agapito, A., Fofanova, O.V., Osorio, M.G., Bircan, I., Moreno, A. & Mendonca, B.B. (1998) The PROP1 2-base pair deletion is a common cause of combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 83, 3346-3349.
43. Deladoey, J., Fluck, C., Buyukgebiz, A., Kuhlmann, B.V., Eble, A., Hindmarsh, P.C., Wu, W. & Mullis, P.E. (1999) 'Hot spot' in the PROP1 gene responsible for combined pituitary hormone deficiency. Journal of Clinical Endocrinology and Metabolism, 84, 1645-1650.
44. Arroyo, A., Pernasetti, F., Vasilyev, V.V., Amato, P., Yen, S.S. & Mellon, P.L. (2002) A unique case of combined pituitary hormone deficiency caused by a PROP1 gene mutation (R120C) associated with normal height and absent puberty. Clinical Endocrinology, 57, 283-291.
45. Parks, J.S., Brown, M.R., Hurley, D.L., Phelps, C.J. & Wajnrajch, M.P. (1999) Heritable disorders of pituitary development. Journal of Clinical Endocrinology and Metabolism, 84, 4362-4370.
46. Agarwal, G., Bhatia, V., Cook, S. & Thomas, P.Q. (2000) Adrenocorticotropin deficiency in combined pituitary hormone deficiency patients homozygous for a novel PROP1 deletion. Journal of Clinical Endocrinology and Metabolism, 85, 4556-4561.
47. Pernasetti, F., Toledo, S.P., Vasilyev, V.V., Hayashida, C.Y., Cogan, J.D., Ferrari, C., Lourenco, D.M. & Mellon, P.L. (2000) Impaired adrenocorticotropin-adrenal axis in combined pituitary hormone deficiency caused by a two-base pair deletion (301-302delAG) in the prophet of Pit-1 gene. Journal of Clinical Endocrinology and Metabolism, 85, 390-397.
48. Mendonca, B.B., Osorio, M.G., Latronico, A.C., Estefan, V., Lo, L.S. & Arnhold, I.J. (1999) Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301, G302 in the PROP1 gene. Journal of Clinical Endocrinology and Metabolism, 84, 942-945.
49. Bottner, A., Keller, E., Kratzsch, J., Stobbe, H., Weigel, J.F., Keller, A., Hirsch, W., Kiess, W., Blum, W.F. & Pfaffle, R. W. (2004) PROP1 mutations cause progressive deterioration of anterior pituitary function including adrenal insufficiency: a longitudinal analysis. Journal of Clinical Endocrinology and Metabolism, 89, 5256-5265.
50. Turton, J.P.G., Reynaud, R., Mehta, A., Torpiano, J., Saveanu, A., Woods, K.S., Tiulpakov, A., Hamilton, J., Attard-Montalto, S., Parascandalo, R., Vella, C., Clayton, P.E., Shalet, S., Barton, J., Brue, T. & Dattani, M.T. (2005) Mutations within the transcription factor PROP1 are rare in a cohort of patients with sporadic combined pituitary hormone deficiency (CPHD). Clinical Endocrinology, in press.
51. Andersen, B. & Rosenfeld, M.G. (2001) POU domain factors in the neuroendocrine system: lessons from developmental biology provide insights into human disease. Endocrine Reviews, 22, 2-35.
52. Rhodes, S.J., DiMattia, G.E. & Rosenfeld, M.G. (1994) Transcriptional mechanisms in anterior pituitary cell differentiation. Current Opinions in Genetics and Development, 4, 709-717.
53. Li, S., Crenshaw, E.B., Rawson, E.J., Simmons, D.M., Swanson, L.W. & Rosenfeld, M.G. (1990) Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature, 347, 528-533.
54. Andersen, B. & Rosenfeld, M.G. (1994) Pit-1 determines cell types during development of the anterior pituitary gland. A model for transcriptional regulation of cell phenotypes in mammalian organogenesis. Journal of Biological Chemistry, 269, 29335-29338.
55. Rhodes, S.J., Chen, R., DiMattia, G.E., Scully, K.M., Kalla, K.A., Lin, S.C., Yu, V.C. & Rosenfeld, M.G. (1993) A tissue-specific enhancer confers Pit-1-dependent morphogen inducibility and autoregulation on the pit-1 gene. Genes and Development, 7, 913-932.
56. Tatsumi, K., Miyai, K., Notomi, T., Kaibe, K., Amino, N., Mizuno, Y. & Kohno, H. (1992) Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nature Genetics, 1, 56-58.
57. Pfaffle, R.W., DiMattia, G.E., Parks, J.S., Brown, M.R., Wit, J.M., Jansen, M., Van-der-Nat, H., Van-den-Brande, J.L., Rosenfeld, M.G. & Ingraham, H.A. (1992) Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science, 257, 1118-1121.
58. Pfaffle, R.W., Martinez, R., Kim, C., Frisch, H., Lebl, J., Otten, B. & Heimann, G. (1997) GH and TSH deficiency. Experimental and Clinical Endocrinology and Diabetes, 105 (Suppl. 4), 1-5.
59. Radovick, S., Du Nations, M.Y., Berg, L.A., Weintraub, B.D. & Wondisford, F.E. (1992) A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science, 257, 1115-1118.
60. Bennani-Baiti, I.M., Asa, S.L., Song, D., Iratni, R., Liebhaber, S.A. & Cooke, N.E. (1998) DNase I-hypersensitive sites I and II of the human growth hormone locus control region are a major developmental activator of somatotrope gene expression. Proceedings of the National Academy of Sciences of the United States of America, 95, 10655-10660.
61. Shewchuk, B.M., Asa, S.L., Cooke, N.E. & Liebhaber, S.A. (1999) Pit-1 binding sites at the somatotrope-specific DNase I hypersensitive sites I, II of the human growth hormone locus control region are essential for in vivo hGH-N gene activation. Journal of Biological Chemistry, 274, 35725-35733.
62. Shewchuk, B.M., Liebhaber, S.A. & Cooke, N.E. (2002) Specification of unique Pit-1 activity in the hGH locus control region. Proceedings of the National Academy of Sciences of the United States of America, 99, 11784-11789.
63. Illig, R. (1970) Growth hormone antibodies in patients treated with different preparations of human growth hormone (HGH). Journal of Clinical Endocrinology and Metabolism, 31, 679-688.
64. Phillips, J.A. III, Hjelle, B.L., Seeburg, P.H. & Zachmann, M. (1981) Molecular basis for familial isolated growth hormone deficiency. Proceedings of the National Academy of Sciences of the United States of America, 78, 6372-6375.
65. Wagner, J.K., Eble, A., Hindmarsh, P.C. & Mullis, P.E. (1998) Prevalence of human GH-1 gene alterations in patients with isolated growth hormone deficiency. Pediatric Research, 43, 105-110.
66. Procter, A.M., Phillips, J.A. & Cooper, D.M. (1998) The molecular genetics of growth hormone deficiency. Human Genetics, 103, 255-272.
67. Wajnrajch, M.P., Gertner, J.M., Harbison, M.D., Chua, S.C. Jr & Leibel, R.L. (1996) Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nature Genetics, 12, 88-90.
68. Carakushansky, M., Whatmore, A.J., Clayton, P.E., Shalet, S.M., Gleeson, H.K., Price, D.A., Levine, M.A. & Salvatori, R. (2003) A new missense mutation in the growth hormone-releasing hormone receptor gene in familial isolated GH deficiency. European Journal of Endocrinology, 148, 25-30.
69. McGuinness, L., Magoulas, C., Sesay, A.K., Mathers, K., Carmignac, D., Manneville, J.B., Christian, H., Phillips, J.A., III. & Robinson, I.C. (2003) Autosomal dominant growth hormone deficiency disrupts secretory vesicles in vitro and in vivo in transgenic mice. Endocrinology, 144, 720-731.
70. Mullis, P.E., Robinson, I.C., Salemi, S., Eble, A., Besson, A., Vuissoz, J.M., Deladoey, J., Simon, D., Czernichow, P. & Binder, G. (2005) Isolated autosomal dominant growth hormone deficiency (IGHD II): an evolving pituitary deficit? A multi-center follow-up study. Journal of Clinical Endocrinology and Metabolism, 90, 2089-2096.
71. Moseley, C.T., Mullis, P.E., Prince, M.A. & Phillips, J.A. III (2002) An exon splice enhancer mutation causes autosomal dominant GH deficiency. Journal of Clinical Endocrinology and Metabolism, 87, 847-852.
72. Mullis, P.E., Deladoey, J. & Dannies, P.S. (2002) New GH-1 gene mutations: expanding the spectrum of causes of isolated growth hormone deficiency. Journal of Paediatric Endocrinology and Metabolism, 15 (Suppl. 5), 1301-1310.
73. Mullis, P.E., Deladoey, J. & Dannies, P.S. (2002) Molecular and cellular basis of isolated dominant-negative growth hormone deficiency, IGHD type II: insights on the secretory pathway of peptide hormones. Hormone Research, 58, 53-66.